Home > Boards > Canadian > Cannabis > Tilray, Inc (TLRY)

TLRY : Tilray resumed with an outperform rating,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FUNMAN Member Profile
Member Level 
Followed By 106
Posts 25,479
Boards Moderated 11
Alias Born 08/03/10
160x600 placeholder
Tilray Expands Medical Cannabis Footprint in Europe Business Wire - 10/26/2021 7:30:00 AM
Tilray: The Most Attractive Canadian Cannabis Play TipRanks - 10/22/2021 5:17:00 AM
Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada Business Wire - 10/20/2021 7:30:00 AM
Tilray Strengthens Leadership Position in Canada Business Wire - 10/19/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/14/2021 9:33:13 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 10/14/2021 9:30:56 AM
Tilray: A “Rather Flat Print” Keeps This Analyst on the Sidelines TipRanks - 10/11/2021 4:01:38 PM
Tilray Reports Mixed Q1 Results; Shares Rise TipRanks - 10/8/2021 1:40:07 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/7/2021 4:38:35 PM
Hot Stocks: TLRY rises on earnings, LW falls; SQ gets Buy rating; COST sales; RKLB contract with NASA Seeking Alpha - 10/7/2021 12:58:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2021 7:11:06 AM
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results Business Wire - 10/7/2021 7:00:00 AM
Tilray Q1 Earnings Preview: What’s Ahead? TipRanks - 10/6/2021 7:25:30 AM
Rising Natural Wellness Momentum Fuels Cannabis Market NetworkNewsWire - 9/30/2021 8:45:00 AM
Latin America, Not US, Spearheading Advancements in Global Cannabis Markets NetworkNewsWire - 9/28/2021 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/24/2021 4:18:39 PM
Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021 Business Wire - 9/23/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2021 4:44:22 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 9/17/2021 4:33:04 PM
Tilray Gains on Aphria Merger, Global Cannabis Operations TipRanks - 9/17/2021 2:28:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2021 4:22:01 PM
Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting Business Wire - 9/10/2021 11:30:00 AM
Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021 Business Wire - 9/8/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/7/2021 4:42:45 PM
Tilray Subsidiary SweetWater Brewing Launches Non-Dairy Almond Milk Stout TipRanks - 9/6/2021 4:48:22 AM
FUNMAN Member Level  Tuesday, 05/11/21 08:47:06 PM
Re: mojo joyo post# 6413
Post # of 7734 
TLRY : Tilray resumed with an outperform rating, Elanco and Shockwave upgraded, and more in today's analyst action • 10:15 AM

Tilray resumed with an outperform rating

Following the closing its acquisition with Aphria earlier this month, Cowen has resumed coverage of Tilray (NASDAQ:TLRY) with an outperform rating and $20 price target.

That implies upside of ~43% from the stock's most recent close.

Analyst Vivien Azer writes that Tilray is now the market share leader in Canada with "best-in-class profitability."

She says the company has about a 19% share of the adult cannabis market, ~420 bps above its closest competitor.

Also, the two companies compliment each other allowing for exposure into different cannabis forms, such as edibles and vaping, as well as into more provinces.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences